Navigation Links
Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and FY 2011 Financial Results
Date:2/27/2012

SAN DIEGO, Feb. 27, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) will report fourth quarter 2011 and fiscal year 2011 financial results and provide a business overview, including DIFICID® sales, commercialization and development, after the NASDAQ Global Market closes on March 7th.  The Company will host a conference call the same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time).

(Logo:  http://photos.prnewswire.com/prnh/20090413/LA97352LOGO )

The conference call may be accessed by dialing (877) 280-7280 for domestic callers and +1 (678) 825-8232 for international callers. Please specify to the operator that you would like to join "Optimer's Financial Results Call."  The conference call will be webcast live under the "Investors" section of Optimer's website at www.optimerpharma.com, where it will be archived for 30 days following the call. 

About Optimer Pharmaceuticals
Optimer Pharmaceuticals, Inc. is a global biopharmaceutical company focused on discovering, developing and commercializing innovative hospital specialty products that have a positive impact on society. Optimer developed and commercialized DIFICID® (fidaxomicin) tablets, an FDA-approved antibacterial drug for the treatment of adult patients with Clostridium difficile-associated diarrhea (CDAD). Optimer has also received marketing authorization for fidaxomicin tablets in the European Union under the trade name DIFICLIR™. The company is seeking marketing authorization for fidaxomicin in Canada and is exploring marketing authorization in other parts of the world where C. difficile has emerged as a serious health problem, including Asia. Additional infor
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
4. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
5. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
7. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
8. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
9. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
10. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
11. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... March 4, 2015 The March 3, 2015, order from ... must change their products, labels to clarify the drugs, intended ... and stroke is necessary to protect the public from injury ... partner at Simmons Hanly Conroy . The ... that the products – currently taken by millions of U.S. ...
(Date:3/4/2015)... CITY, Kan. , March 4, 2015   ... a pet therapeutics company focused on the licensing, development ... today announced that it will present at the ... 10-12, 2015, at the Loews Miami Beach Hotel in ... Steven St. Peter , M.D., President and Chief ...
(Date:3/4/2015)... N.J. , March 4, 2015  Bayer ... Drug Administration (FDA) has accepted the company,s Biologics ... Factor VIII compound.  Bayer is seeking FDA approval ... for the treatment of hemophilia A in children ... to continually bringing new therapies to hemophilia A ...
Breaking Medicine Technology:Simmons Hanly Conroy, LLC: FDA Orders Label Warnings on Testosterone Drugs Concerning Normal Aging Use and Heart Attack-Stroke Risks 2Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 3
... , May 10 /PRNewswire-Asia/ -- On April ... cases with Beijing Un-Assegai Technical &,Trade Co. Ltd. (hereinafter referred ... China , as claimant and U.S. Abbott,Laboratories (Abbott U.S.; ... by the,China International Economic and Trade Arbitration Commission (CIETAC), which,has ...
... , Fla., May 10 Dr. Richard ... with newly diagnosed type 1 diabetes for Protege Encore, a ... of two Phase III studies testing the safety and efficacy ... as Protege, has completed enrollment of more than 530 subjects ...
Cached Medicine Technology:Assegai Wins Big Settlement Against ABBOTT's Subsidiary 2Protege Encore Clinical Trial Evaluates New Investigational Approach For Individuals Recently Diagnosed With Type 1 Diabetes 2
(Date:3/5/2015)... COVINGTON, LOUISIANA (PRWEB) March 05, 2015 ... announce its continued support of the annual American Heart ... This year, Bret Kolman, Lakeview Regional Chief Executive Officer, ... take place on Saturday, March 21, 2015 at Fontainebleau ... event sponsorship, Lakeview Regional has 20 individual teams participating ...
(Date:3/5/2015)... New fiber fix heat wrap, a fiber glass adhesive launched ... kind product, manufactured to withstand the highest of temperatures. This ... in the market by customers who look to mold together ... cannot be done with the usual adhesives. , A spokesperson ... our new product Fiber Fix Heat Warp and already see ...
(Date:3/5/2015)... The cornerstone of the Vacuworx design ... smarter commercial lifting system and with the introduction of ... in more green construction projects . , Vacuworx ... System for lifting concrete road slabs and the Hydraulic ... projects. , The Octapad System was designed with ...
(Date:3/5/2015)... March 05, 2015 March is ... information campaign sponsored by the Academy of Nutrition ... a Healthy Lifestyle," which promotes the consumption of ... for achieving and maintaining a healthy weight, reducing ... , Whether a person is new to ...
(Date:3/5/2015)... Medical professionals suggest the physician shortage is no ... is worsening. The demand for doctors far exceeds the ... of the physician shortage, health care organizations and medical ... physicians and advanced practitioners throughout the U.S. through a ... Physician openings take an average of 204 days to ...
Breaking Medicine News(10 mins):Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 2Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 3Health News:TheHardwareCity.com Launches New Fiber Fix Heat Wrap For High Temperature Applications 2Health News:New Vacuworx Concrete Lifting Systems Aid Safer, Greener Environment As Contractors Seek LEED Incentives 2Health News:New Vacuworx Concrete Lifting Systems Aid Safer, Greener Environment As Contractors Seek LEED Incentives 3Health News:National Nutrition Month® Tips for Athletes from the Austin Sports Medicine Team at Medicine in Motion 2Health News:National Nutrition Month® Tips for Athletes from the Austin Sports Medicine Team at Medicine in Motion 3Health News:Physician Shortage Crisis Worsening 2
... painful rashes. Prescription medications including steroid creams that ... ,When over five million Americans suffer from that ... frenzied response, especially when backed by some kind of ... even though experts are skeptical. ,"We can ...
... of anthropologists have embarked on a project to save Tibetan ... professor Gerald Roche, the volunteer-run Tibetan Endangered Music Project (TEMP) ... and return them back to the community. ,"The ... them to our communities. We want to record as many ...
... countries holding an international summit on bird flu in Aviemore ... birds are not an answer to the outbreaks of ... the Avian Flu Task Force under the UN international convention ... wild birds have been infected in some cases, the scientists ...
... to help people quit smoking? Get a national TV network ... of a new study that found calls to a national ... anchor Peter Jennings death from lung cancer. ,Its ... also have to advertise it, said Erik Augustson, a behavioral ...
... be negative, write Professor Desmond O'Neill and colleagues. Yet ... prudent driving behaviours. Furthermore, stopping driving can limit ... independent risk factor for entry into a nursing home. ... therefore try to balance mobility and safety in the ...
... Alteon Inc. announced today that it has dosed ... trial (Study 201) of ALT-2074, its lead glutathione peroxidase ... haptoglobin that renders them at high risk for cardiovascular ... designed to evaluate ALT-2074's ability to lower inflammatory cardiovascular ...
Cached Medicine News:Health News:Experts Critical of a New OTC Product to Treat Psoriasis 2Health News:Experts Critical of a New OTC Product to Treat Psoriasis 3Health News:Digital Music Project Aims to Save Tibetan Folk Songs from Extinction 2Health News:National TV Promotion Triples Calls to Smoking Cessation Hotline 2Health News:Alteon Initiates Phase 2 Trial of ALT-2074 in Diabetes and Haptoglobin 2-2 2
... enables highly sensitive time-resolved fluorescence detection ... fluorophores. These compounds are excited with ... fluorescence lifetimes (several hundred microseconds), large ... profiles at 620 nm. Therefore with ...
... most advanced multi-functional microplate detection system, ... performance without compromising flexibility. ,The ... on the Ultra instrument platform. New ... adds to the flexibility of the ...
... OPTIMA is a fully automated microplate ... different measurement principles:, , Fluorescence Polarization ... Fluorescence , High-Performance Luminescence (flash ... ,It is designed for the ...
... FLUOstar is a flexible multifunction plate reader ... one instrument: fluorescence intensity, time-resolved fluorescence, high-perfomance ... be equipped with injectors that deliver reagent ... fast kinetic cell assays can be performed ...
Medicine Products: